AbbVie faces hepatitis C patent challenge in India

Search this blog: Health Society Women

AbbVie faces hepatitis C patent challenge in India

भारत मानक समय — शुक्रवार, जुलाई 27, 2018

AbbVie faces hepatitis C patent challenge in India
- I-MAK has successfully challenged patents on four HIV drugs in India. Prices for these generic medicines are 51% to 89% lower than the branded ...

Fix your gut health to prevent diabetes, hypertension, tells study

भारत मानक समय — शुक्रवार, अप्रैल 19, 2024

What is HPV Vaccination?

भारत मानक समय — बुधवार, अप्रैल 03, 2024

Conservation and climate change: Will the balancing act save the giant flying bird?

भारत मानक समय — मंगलवार, अप्रैल 16, 2024

Study Finds Plant-Based Meat Alternatives Do Not Offer Cardiometabolic Health Benefits Over Meat

भारत मानक समय — शुक्रवार, अप्रैल 19, 2024

Stigmabase | भारत

AbbVie faces hepatitis C patent challenge in India

Top stories of the last 30 days

Fix your gut health to prevent diabetes, hypertension, tells study

What is HPV Vaccination?

Conservation and climate change: Will the balancing act save the giant flying bird?

Study Finds Plant-Based Meat Alternatives Do Not Offer Cardiometabolic Health Benefits Over Meat

What does stress do to your gut health? Here's all you need to know

10 non-dairy foods that help build and maintain strong bones

Climate change threatens constitutional guarantee of right to equality

UK's 'artificial pancreas' to transform lives of type 1 diabetes patients